Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...
New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors detect and track cancerous cells. Prostate cancer is the most common cancer ...
To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...
Morning Overview on MSN
A targeted drug won approval for a hard-to-treat form of advanced prostate cancer
Men diagnosed with metastatic hormone-sensitive prostate cancer who carry a specific tumor deficiency now have a targeted ...
Prostate health awareness helps men identify early signs, understand risks, and navigate PSA tests and screening with trusted ...
Stage 1 prostate adenocarcinoma is localized, non-aggressive, and often detected through routine screenings like PSA tests and DREs. Diagnosis involves PSA levels, Gleason scores, and possibly ...
Millions of men face a decision about whether to be screened for prostate cancer. National guidelines say that decision ...
AMPLIFY: A phase 3 study of 64Cu-SAR-bisPSMA positron emission tomography in participants with biochemical recurrence of prostate cancer. SOLACE: A phase 1 pharmacokinetic, dosimetry, safety, and dose ...
For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results